Atlas Trials

A Study to Evaluate the Efficacy and Safety of Orally Administered Extract of Orthosiphon Stamineus (NuvastaticTM-C5OSEW5050ESA) in Patient With Breast Cancer Undergoing Chemotherapy

Clinical trial NCT07669506 · COMPLETED

Trial details

NCT number
NCT07669506
Sponsor
Natureceuticals Sdn Bhd
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast NeoplasmsFatigueQuality of LifeChemotherapy, Adjuvant
Start date
2025-06-17
Primary completion
2026-04-25
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.